… in short-term trials of interferon (IFN) due to the slow natural course of chronic hepatitis B.
A major issue of concern is the fact that RCTs of IFN for chronic hepatitis B have been mostly …

… Administration of interferon to patients with chronic hepatitis D can neither be supported nor
refuted. Interferon may benefit some patients through long‐term remission. The patients run …

… the antiviral agent interferon alfa, we randomly assigned 166 patients with chronic hepatitis
C to treatment with either 3 million or 1 million units of recombinant interferon alfa three times …

… IFN-α treatment of chronic hepatitis. … IFN-α treatment for chronic hepatitis C is associated
with a significant prefrontal hypometabolism [18]. There are also functional links between IFN-α …

… Chronic hepatitis D is a … with interferon, we studied 42 patients with chronic hepatitis D who
were randomly assigned to receive either 9 million or 3 million units of recombinant interferon …

… hepatitis C virus RNA or antigens, we found that interferon … in over half the patients with
chronic hepatitis C. Perhaps more … that interferon may modify the hepatic effects of hepatitis C …

… of standard IFN-α and PEG-IFN-α in the treatment of chronic hepatitis C and … chronic
hepatitis C or liver cirrhosis (ie, PEG-IFN-α plus RBV combination therapy), IFN-α and PEG-IFN-α …

… Our data thus provide further evidence of a benefit of interferon alfa in patients with
chronic hepatitis B and may also be used in cost–benefit and cost-effectiveness analyses. …

… remissions in chronic hepatitis B induced by IFN-a are with chronic hepatitis B. The aim of …
All patients sponse, but with adjustment for cirrhosis, nonrespondhad chronic hepatitis B with …

… Alpha interferon is available worldwide as at least six dif- Alpha interferons have been
used widely to treat chronic hepatitis C virus infection. These include recombinant inter- ferent …